Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at Dansk Aktionærforening InvestorDagen
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Clinical phase II trial of uPAR-PET in brain cancer patients published; data supports development of uTREAT for brain cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S announces last day of trading in BTU and first day of trading in warrant series TO2 and TO3
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S announces last day of trading in BTU and first day of trading in warrant series TO2 and TO3
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S rights issue heavily oversubscribed
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Commencement of subscription period in Curasight’s preferential rights issue
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S publishes prospectus due to upcoming rights issue
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S publishes prospectus due to upcoming rights issue
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: The Board of Directors resolves on a directed issue of units and preferential rights issue of units
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim report Q2 2024